Sort by
Refine Your Search
-
disorders, with a particular emphasis on glycogen storage diseases (GSDs), including GSD type II (Pompe disease). The postdoc will contribute to advancing understanding of the natural history of GSDs and
-
therapeutic resistance in lung and head and neck cancers using integrated genetic, molecular, and computational approaches. We are particularly interested in discovering new therapeutic vulnerabilities and
-
. Postdoctoral Associate – Translational Microbiome and Critical Care Research The Duke Anesthesiology Microbiome Profiling (AMP) Laboratory (https://anesthesiology.duke.edu/research/serbanescu-lab) under Dr
-
issued to sponsor the individual. The term of the appointment is limited (see Section 5 of the Postdoc Policy for length of appointment). The appointment involves substantially full-time research
-
. Review of applications will begin immediately and continue until the position is filled. Additional information about the Hsu-Kim research group: https://hsukim.pratt.duke.edu/ Duke University is an Equal
-
-throughput genomic screening approaches, primary cell culture systems, and animal models of influenza disease. For more information visit https://mgm.duke.edu/faculty-and-research/primary-faculty/nicholas
-
, visit: https://sites.duke.edu/yokoyamalab/ Duke is an Equal Opportunity Employer committed to providing employment opportunity without regard to an individual's age, color, disability, gender, gender
-
, generous retirement benefits, and a wide array of family-friendly andcultural programs to eligible team members. Learn more at: https://hr.duke.edu/benefits/ Equal Opportunity Employer: Duke is an Equal
-
collaboratively in an interdisciplinary team • Capacity to manage projects and timelines independently • Comfort giving and receiving feedback in a fast-moving, idea-rich environment Timeline: The postdoc can begin
-
multiple affiliations. Computational Immunobiology Postdoctoral Associate Position (Williams) Be You. The Duke Human Vaccine Institute (DHVI) continues to lead cutting edge vaccine research against